Bezin, Julien
Université de Bordeaux · Inserm · Centre Hospitalier Universitaire de Bordeaux · Bordeaux Population Health
4 papers on CoChatORCID 0000-0002-2568-1928
Most cited papers
- Verified
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
Bezin, J., Gouverneur, A., Pénichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J.-L. (2023) · Diabetes Care
Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment
Cited by 320
- Verified
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
Rosellini, P., Amintas, S., Caumont, C., Veillon, R., Galland-Girodet, S., Cuguillière, A., Nguyen, L., Domblides, C., Gouverneur, A., Merlio, J.-P., et al. (2022) · European Journal of Cancer
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 44
- Verified
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study
Tournier, M., Bénard‐Laribière, A., Jollant, F., Hucteau, E., Diop, P., Jarne‐Munoz, A., Pariente, A., Oger, E., & Bezin, J. (2023) · Acta Psychiatrica Scandinavica
Suicide and Self-Harm StudiesOpioid Use Disorder Treatment
Cited by 35
- Verified
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Bezin, J., Mathieu, C., Faillie, J.-L., & Pariente, A. (2023) · Diabetes Care
Diabetes Treatment and ManagementThyroid Disorders and Treatments
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free